Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SIBIA to file Parkinson's therapy IND in late 1996/early 1997 -- IPO prospectus.

Executive Summary

SIBIA TO FILE PARKINSON's THERAPY IND IN LATE 1996/EARLY 1997, a "red herring" prospectus for the La Jolla, Calif.-based company's initial public offering reports. SIBIA Neurosciences (formerly the Salk Institute Biotechnology/Industrial Associates) is seeking a corporate partner for the compound, SIB-1508Y, which exhibits subtype-selective nicotinic acetylcholine receptor agonist activity.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028190

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel